Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Paul M. Barr
Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax Treated CLL in Routine Clinical Practice
Clinical Cancer Research
Cancer Research
Oncology
Long-Term Follow-Up of the RESONATE™ Phase 3 Trial of Ibrutinib Versus Ofatumumab
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Cellular Cytotoxicity of Next Generation CD20 Monoclonal Antibodies
Cancer immunology research
Cancer Research
Immunology
Comparative Analysis of Targeted Novel Therapies in Relapsed, Refractory Chronic Lymphocytic Leukaemia
Haematologica
Hematology
Significant Weight Gain in CLL Patients Treated With Ibrutinib: A Potentially Deleterious Consequence of Therapy
American Journal of Hematology
Hematology
Tumour Debulking and Reduction in Predicted Risk of Tumour Lysis Syndrome With Single-Agent Ibrutinib in Patients With Chronic Lymphocytic Leukaemia
British Journal of Haematology
Hematology